ASSESSMENT OF RESPONSE TO LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN ADDITION TO RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA USING FET PET

被引：0
|
作者：
Werner, J. [1 ,2 ]
Wollring, M. M. [1 ,2 ]
Tscherpel, C. [1 ,2 ,3 ]
Rosen, E. K. [1 ,2 ]
Ceccon, G. [1 ,2 ]
Stetter, I [1 ,2 ]
Lohmann, P. [4 ,5 ]
Weller, J. [6 ]
Stoffels, G. [4 ]
Baues, C. [7 ,8 ]
Celik, E. [7 ,8 ]
Mottaghy, F. M.
Goldbrunner, R. [2 ,9 ]
Herrlinger, U.
Fink, G. R. [1 ,2 ,4 ]
Langen, K. [4 ]
Galldiks, N. [1 ,2 ,4 ,5 ]
机构：
[1] Univ Cologne, Fac Med, Dept Neurol, Cologne, Germany
[2] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[3] Goethe Univ, Univ Hosp Frankfurt, Dept Neurol, Frankfurt, Germany
[4] Res Ctr Juelich, Inst Neurosci & Med INM 3 INM 4, Julich, Germany
[5] RWTH Univ Hosp, Dept Nucl Med, Aachen, Germany
[6] Univ Hosp Bonn, Ctr Neurol, Dept Neurooncol, Bonn, Germany
[7] Ruhr Univ Bochum, Marien Hosp Herne, Fac Med, Dept Radiat Oncol, Bochum, Germany
[8] Ruhr Univ Bochum, Univ Hosp, Marien Hosp Herne, Bochum, Germany
[9] Univ Cologne, Fac Med, Dept Gen Neurosurg, Cologne, Germany
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae144.162
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P09.03.B
引用
收藏
页码：V50 / V50
页数：1
相关论文
共 50 条
  • [1] ASSESSMENT OF RESPONSE TO LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN ADDITION TO RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA USING FET PET
    Werner, Jan-Michael
    Wollring, Michael M.
    Tscherpel, Caroline
    Rosen, Elena K.
    Ceccon, Garry
    Stetter, Isabelle
    Lohmann, Philipp
    Weller, Johannes
    Stoffels, Gabriele
    Baues, Christian
    Celik, Eren
    Mottaghy, Felix M.
    Goldbrunner, Roland
    Herrlinger, Ulrich
    Fink, Gereon R.
    Langen, Karl-Josef
    Galldiks, Norbert
    NEURO-ONCOLOGY, 2024, 26
  • [2] DIAGNOSIS OF PSEUDOPROGRESSION FOLLOWING RADIOTHERAPY PLUS LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS USING FET PET
    Werner, Jan-Michael
    Ceccon, Garry
    Weller, Johannes
    Schaub, Christina
    Tscherpel, Caroline
    Lohmann, Philipp
    Bauer, Elena
    Schaefer, Niklas
    Stoffels, Gabriele
    Kabbasch, Christoph
    Baues, Christian
    Marnitz, Simone
    Fink, Gereon R.
    Langen, Karl-Josef
    Herrlinger, Ulrich
    Galldiks, Norbert
    NEURO-ONCOLOGY, 2020, 22 : 152 - 153
  • [3] Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
    Werner, Jan-Michael
    Weller, Johannes
    Ceccon, Garry
    Schaub, Christina
    Tscherpel, Caroline
    Lohmann, Philipp
    Bauer, Elena K.
    Schaefer, Niklas
    Stoffels, Gabriele
    Baues, Christian
    Celik, Eren
    Marnitz, Simone
    Kabbasch, Christoph
    Gielen, Gerrit H.
    Fink, Gereon R.
    Langen, Karl-Josef
    Herrlinger, Ulrich
    Galldiks, Norbert
    CLINICAL CANCER RESEARCH, 2021, 27 (13) : 3704 - 3713
  • [4] Lomustine-temozolomide combination efficacious in newly diagnosed glioblastoma
    Killock, David
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (05) : 273 - 273
  • [5] Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03
    Herrlinger, Ulrich
    Rieger, Johannes
    Koch, Dorothee
    Loeser, Simon
    Blaschke, Britta
    Kortmann, Rolf-Dieter
    Steinbach, Joachim P.
    Hundsberger, Thomas
    Wick, Wolfgang
    Meyermann, Richard
    Tan, Ta-Chih
    Sommer, Clemens
    Bamberg, Michael
    Reifenberger, Guido
    Weller, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4412 - 4417
  • [6] TEMOCAR: CARBOPLATIN IN ADDITION TO RADIOTHERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED UNRESECTABLE GLIOBLASTOMA
    Pecuchet, N.
    Feuvret, L.
    Assouline, A.
    Hemery, C.
    Lang, P.
    Lopez, S.
    Hoang-Xuan, K.
    Delattre, J.
    Mazeron, J.
    Simon, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 331 - 331
  • [7] The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
    Sidsel Højklint Poulsen
    Thomas Urup
    Kirsten Grunnet
    Ib Jarle Christensen
    Vibeke Andrée Larsen
    Michael Lundemann Jensen
    Per Munck af Rosenschöld
    Hans Skovgaard Poulsen
    Ian Law
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 373 - 381
  • [8] The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
    Poulsen, Sidsel Hojklint
    Urup, Thomas
    Grunnet, Kirsten
    Christensen, Ib Jarle
    Larsen, Vibeke Andree
    Jensen, Michael Lundemann
    af Rosenschold, Per Munck
    Poulsen, Hans Skovgaard
    Law, Ian
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (03) : 373 - 381
  • [9] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaros Lazaridis
    Niklas Schäfer
    Sarah Teuber-Hanselmann
    Tobias Blau
    Teresa Schmidt
    Christoph Oster
    Johannes Weller
    Theophilos Tzaridis
    Daniela Pierscianek
    Kathy Keyvani
    Christoph Kleinschnitz
    Martin Stuschke
    Björn Scheffler
    Cornelius Deuschl
    Ulrich Sure
    Ulrich Herrlinger
    Sied Kebir
    Martin Glas
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 787 - 792
  • [10] Combination Therapy of Lomustine and Temozolomide in Patients with newly diagnosed Glioblastoma with methylated MGMT Promotor
    Lenzen, Julia
    Feldmann, H. J.
    ONKOLOGE, 2019, 25 (12): : 1118 - 1120
12345